Clinical Trial: A Clinical Trial to Evaluate the Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living with Type 1 Diabetes

U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT06894784) titled 'A Clinical Trial to Evaluate the Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living with Type 1 Diabetes' on March 07.

Brief Summary: The goal of this clinical trial is to learn if Empagliflozin and Semaglutide, individually and combined, added to Automated Insulin Delivery (AID) works to improve time-in-range in adults living with Type 1 Diabetes. It will also evaluate the safety of Empagliflozin and Semaglutide in this context.

The primary hypothesis of this study is :

- The combination therapy of semaglutide and empagliflozin will increase time-in-range compared...